Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel

Nitai Levy; Jordanna H Koppel; Or Kaplan; Hadas Yechiam; Keren Shahar-Nissan; Naama Kuchinski Cohen; Itai Shavit

doi:10.1001/jama.2022.8025

Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel

JAMA. 2022 Jun 28;327(24):2452-2454. doi: 10.1001/jama.2022.8025.

Authors

Nitai Levy¹, Jordanna H Koppel², Or Kaplan³, Hadas Yechiam⁴, Keren Shahar-Nissan⁵, Naama Kuchinski Cohen⁶, Itai Shavit¹

Affiliations

¹ Pediatric Emergency Department, Rambam Health Care Campus, Haifa, Israel.
² Pediatric Emergency Department, Sheba Medical Center, Tel Hashomer, Israel.
³ Pediatric Emergency Department, Soroka Medical Center, Beer Sheva, Israel.
⁴ Pediatric Emergency Department, Meir Medical Center, Kfar Saba, Israel.
⁵ Emergency Department, Schneider Children's Medical Center, Petah Tikva, Israel.
⁶ Pediatric Emergency Department, Hillel Yaffe Medical Center, Hadera, Israel.

Abstract

This study examines outcomes of multisystem inflammatory syndrome in children during the Alpha, Delta, and Omicron variant waves of the COVID-19 pandemic in Israel.

MeSH terms

COVID-19* / complications
Child
Humans
Incidence
Israel / epidemiology
Pandemics* / statistics & numerical data
Patient Acuity
SARS-CoV-2
Systemic Inflammatory Response Syndrome* / diagnosis
Systemic Inflammatory Response Syndrome* / epidemiology

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related